| Age at diagnosis (±SD) (years) | 74.8 ± 6.3 |
| Initial PSA (ng/mL) | 537.3 ± 999 (median: 132, range: 2 - 3770) |
| Gleason score (case) | |
| 6 | 2 |
| 7 | 3 |
| 8 - 10 | 6 |
| not done | 3 |
| Clinical stage at diagnosis (case) | |
| B | 3 |
| C | 3 |
| D | 8 |
| Age at alteration (±SD) (years) | 81.4 ± 4.3 |
| Duration of agonist (months) | 79.6 ± 63.9 |
| PSA before alterarion (ng/mL) | 28.6 ± 35.0 |
| PSAV before alteration (ng/mL/year) | 43.3 ± 66.4 |
| LH before alteration (mIU/mL) | <0.1 |
| FSH before alteration (mIU/mL) | 3.4 ± 2.7 |
| Testosterone before alteration (ng/mL) | <0.03 |
| PSAV: PSA velocity | Mean ± SD |